Sterile Water

Water


Baxter Healthcare Corporation
Human Prescription Drug
NDC 0338-0004
Sterile Water also known as Water is a human prescription drug labeled by 'Baxter Healthcare Corporation'. National Drug Code (NDC) number for Sterile Water is 0338-0004. This drug is available in dosage form of Irrigant. The names of the active, medicinal ingredients in Sterile Water drug includes Water - 100 mL/100mL . The currest status of Sterile Water drug is Active.

Drug Information:

Drug NDC: 0338-0004
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Sterile Water
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Prescription Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Water
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Baxter Healthcare Corporation
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Irrigant
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:WATER - 100 mL/100mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:IRRIGATION
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: NDA
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 31 Dec, 1974
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 14 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: NDA017428
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Baxter Healthcare Corporation
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:150985
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:059QF0KO0R
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
0338-0004-0224 BOTTLE, PLASTIC in 1 CARTON (0338-0004-02) / 250 mL in 1 BOTTLE, PLASTIC31 Dec, 1974N/ANo
0338-0004-0318 BOTTLE, PLASTIC in 1 CARTON (0338-0004-03) / 500 mL in 1 BOTTLE, PLASTIC31 Dec, 1974N/ANo
0338-0004-0412 BOTTLE, PLASTIC in 1 CARTON (0338-0004-04) / 1000 mL in 1 BOTTLE, PLASTIC31 Dec, 1974N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Product Elements:

Sterile water water water water sterile water water water water

Indications and Usage:

1 indications and usage sterile water for irrigation is indicated for use as an irrigant. sterile water for irrigation is indicated for use as an irrigant. ( 1 )

Warnings and Cautions:

5 warnings and precautions • hypotonicity : administration by parenteral routes can result in serious adverse reactions. for irrigation use only. ( 5.1 ) • excessive water absorption : may result in hyponatremia, hypoosmolality and fluid overload. monitor patients for absorption of clinically relevant amounts of fluid during and after the procedure. additional monitoring is recommended for patients at increased risk of developing complications of fluid overload syndrome (e.g., patients with renal or cardiac impairment) or hyponatremic encephalopathy (e.g., pediatric patients; women, in particular premenopausal women; patients with hypoxemia; and patients with central nervous system disease). avoid use in procedures that require longer irrigation times or an irrigation fluid pressure that promotes absorption. ( 5.2 , 8.4 ) • use with electrosurgery/cautery : ensure compatibility with equipment used with electrosurgery or cautery. ( 5.2 ) 5.1 hypotonicity sterile water for
irrigation is hypotonic with an osmolarity of zero mosmol/l. it is intended for use as irrigation fluid and not for intravenous administration or administration by other, usual parenteral routes, such as intravascular administration in general, subcutaneous administration, or intramuscular administration. serious adverse reactions, including cerebral or pulmonary edema, massive hemolysis, and acute renal failure can result from the hypotonicity of sterile water for irrigation [see warnings and precautions (5.2) ]. 5.2 excessive water absorption due to the hypotonicity, absorption of sterile water for irrigation can result in serious adverse reactions of hyponatremia, hypoosmolality and fluid overload, resulting in fatality or permanent morbidity. complications include cerebral edema, encephalopathy, pulmonary edema, massive hemolysis, rhabdomyolysis, renal failure, and hyperkalemia [see adverse reactions (6) ]. in addition, excessive volume or pressure of the irrigation fluid may also cause undue distension of body cavities and may cause tissue disruption (e.g., tears or perforation). these complications can manifest after irrigation has ended and immediate intervention may be required. monitor patients closely for absorption of clinically relevant amounts of fluid during and for an appropriate period after the procedure. if absorption occurs, discontinue sterile water for irrigation. additional close monitoring during and/or after the procedure is recommended for patients at increased risk for developing complications related to hypotonicity, such as: • fluid overload syndrome, including patients with severe renal impairment, impaired cardiac function, or other clinical conditions associated with edematous states. • hyponatremic encephalopathy, including pediatric patients; women, in particular premenopausal women; patients with hypoxemia; and patients with underlying central nervous system disease. avoid use of sterile water for irrigation in patients with wounds where significant absorption may occur, such as procedures that require irrigation over a longer period of time or an irrigation fluid pressure that promotes absorption (e.g., transurethral resection of prostate). sterile water for irrigation should only be used by clinicians familiar with the treatment of possible complications. 5.3 use with electrosurgery/cautery in contrast to other irrigation fluids containing electrolytes, sterile water for irrigation is non-conductive. therefore, when choosing the distension solution/fluid used with electrosurgery or cautery, ensure compatibility with the equipment.

Dosage and Administration:

2 dosage and administration • for irrigation only. not for injection or infusion by usual parenteral routes. ( 2.1 , 5.1 ) • the volume and/or rate of irrigation depend on the type of the procedure and the capacity or the surface area of the structure to be irrigated. ( 2.2 ) • for preparation and administration instructions see the full prescribing information. ( 2.1 , 2.3 ) 2.1 important administration instructions • for irrigation only. not for intravenous injection. • sterile water for irrigation is hypotonic with an osmolarity of zero mosmol/l. it is intended for use as an irrigation fluid and not for intravenous administration or administration by other, parenteral routes (e.g., subcutaneous or intramuscular) [see warnings and precautions (5.1) ]. • sterile water for irrigation is not potable water and is not intended for oral administration. • sterile water for irrigation that has been warmed must not be returned to storage. 2.2 recommended dos
age the volume and/or rate of irrigation depend on the type of the procedure and the capacity or the surface area of the structure to be irrigated. 2.3 preparation and administration instructions for single-dose only. sterile water for irrigation is available in a flexible plastic container and a plastic pour bottle. use the contents of the opened container immediately to minimize the potential for bacterial growth and pyrogen formation. discard the unused contents of opened containers, as sterile water for irrigation contains no antimicrobial preservative. adding medications to either the flexible plastic container or the plastic pour bottle • use aseptic technique when making additions to sterile water for irrigation. • additives may be incompatible with sterile water for irrigation. • the compatibility of additives with sterile water for irrigation must be assessed. before introducing additives, check for a possible color change and/or the appearance of precipitates, insoluble complexes, or crystals. • before adding a substance or medication, verify that it is soluble and/or stable in water and that the ph range of sterile water for irrigation is appropriate. • additives known or determined to be incompatible should not be used. • mix thoroughly after additives have been introduced. • use immediately. administration instructions for irrigation by gravity using the flexible plastic container 1. use aseptic technique. 2. tear overwrap down side at slit and remove solution container. visually inspect the container. if the outlet port protector is damaged, detached, or not present, discard container as solution path sterility may be impaired. some opacity of the plastic due to moisture absorption during the sterilization process may be observed. this is normal and does not affect the solution quality or safety. the opacity will diminish gradually. check for minute leaks by squeezing the container firmly. if leaks are found, discard solution as sterility may be impaired. 3. suspend container using hanger hole. 4. remove plastic protector from outlet port at bottom of container. 5. attach irrigation set. refer to complete directions accompanying set. warming if desired, warm the flexible plastic container in overwrap to near body temperature in a water bath or fluid warmer heated to not more than 45°c. microwave heating of irrigation fluids is not recommended. administration using the plastic pour bottle 1. inspect sterile water for irrigation visually for particulate matter and discoloration prior to use. discard if the fluid is not clear or the seal is broken. 2. use aseptic technique 3. remove the plastic shrink band by tearing along the perforation line and unscrew the bottle cap. 4. prevent contact of the fluid with the external surface of the container (including the thread for the bottle cap of the plastic pour bottle). warming if desired, warm the plastic pour bottle in a fluid warmer to not more than 50°c for a maximum of 60 days. discard after 60 days of warming. microwave heating of irrigation fluids is not recommended.

Dosage Forms and Strength:

3 dosage forms and strengths irrigation: • 250, 500, 1000, and 1500 ml sterile water for irrigation in a single-dose plastic pour bottle • 1000, 2000 and 3000 ml sterile water for irrigation in a single-dose flexible plastic container • 250, 500, 1000, and 1500 ml sterile water for irrigation in a single-dose plastic pour bottle. ( 3 ) • 1000, 2000 and 3000 ml sterile water for irrigation in a single-dose flexible plastic container. ( 3 )

Contraindications:

4 contraindications none. • none. ( 4 )

Adverse Reactions:

6 adverse reactions the following adverse reactions have been identified during post approval use of sterile water for irrigation. because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. metabolism and nutrition disorders : hyponatremia, fluid overload, fluid absorption, electrolyte imbalance nervous system disorders : cerebral edema general disorders and administration site conditions : burning sensation (with irrigation of eyes and skin wounds) musculoskeletal and connective tissue disorders : rhabdomyolysis (myoglobinuria) renal and urinary disorders : renal failure other adverse reactions which may occur in association with absorption of water for irrigation include: blood and lymphatic system disorders : hemolysis (hemoglobinemia, hemoglobinuria) metabolism and nutrition disorders : hypervolemia, hypoosmolality, hyperkalemia, acid/base b
alance disorder nervous system disorders : encephalopathy (seizure, loss of vision, lethargy, disorientation, irritability, vomiting, nausea, headache) cardiac disorders : cardiac arrest, cardiac failure, bradycardia, electrocardiogram abnormal vascular disorders : hypertension, postoperative hypotension respiratory, thoracic and mediastinal disorders: respiratory arrest, respiratory failure, pulmonary edema most common adverse reactions are: hyponatremia, fluid overload, fluid absorption, electrolyte imbalance. ( 6 ) to report suspected adverse reactions, contact baxter healthcare corporation at 1-866-888-2472 or fda at 1-800-fda-1088 or www.fda.gov/medwatch.

Use in Specific Population:

8 use in specific populations 8.1 pregnancy risk summary appropriate administration of sterile water for irrigation is not expected to cause adverse developmental outcomes. there are no available data on sterile water for irrigation use in pregnant women to determine a drug-associated risk of adverse developmental outcomes. animal reproduction studies have not been conducted with sterile water for irrigation. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20% respectively. 8.2 lactation risk summary appropriate administration of sterile water for irrigation is not expected to cause harm to a breastfed infant. there are no data on the presence of sterile water for irrigation in either human or animal milk, the effects on the breastfed infant or the effects on milk production. the lack of c
linical data during lactation precludes a clear determination of the risk of sterile water for irrigation to a breastfed infant; therefore, the developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for sterile water for irrigation and any potential adverse effects on the breastfed infant from sterile water for irrigation or from the underlying maternal condition. 8.4 pediatric use safety and effectiveness in pediatric patients have not been established. pediatric patients are at higher risk compared to adults for developing encephalopathy as a complication of hyponatremia, if there is excessive absorption of sterile water for irrigation [see warnings and precautions (5.2) ]. 8.5 geriatric use sterile water for irrigation should be used cautiously in older patients. geriatric patients are more likely to have decreased cardiac, renal, or hepatic function, and other diseases or concomitant drug therapy.

Use in Pregnancy:

8.1 pregnancy risk summary appropriate administration of sterile water for irrigation is not expected to cause adverse developmental outcomes. there are no available data on sterile water for irrigation use in pregnant women to determine a drug-associated risk of adverse developmental outcomes. animal reproduction studies have not been conducted with sterile water for irrigation. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20% respectively.

Pediatric Use:

8.4 pediatric use safety and effectiveness in pediatric patients have not been established. pediatric patients are at higher risk compared to adults for developing encephalopathy as a complication of hyponatremia, if there is excessive absorption of sterile water for irrigation [see warnings and precautions (5.2) ].

Geriatric Use:

8.5 geriatric use sterile water for irrigation should be used cautiously in older patients. geriatric patients are more likely to have decreased cardiac, renal, or hepatic function, and other diseases or concomitant drug therapy.

Overdosage:

10 overdosage excessive rate, volume, pressure or duration of irrigation with hypotonic fluid can result in excessive fluid absorption and permanent morbidity or death as a result of hyponatremia, hypoosmolality and/or fluid overload. in the event of clinically relevant absorption of sterile water for irrigation, immediate intervention may be required [see warnings and precautions (5.2) ].

Description:

11 description sterile water for irrigation contains water that is sterilized and packaged for use as an irrigant. no antimicrobial agent or other substance has been added. the ph is 5.5 (5.0 to 7.0). sterile water for irrigation is hypotonic with an osmolarity of zero mosmol/l. the flexible plastic container is fabricated from a specially formulated polyvinyl chloride. the amount of water that can permeate from inside the container into the overwrap is insufficient to affect the fluid significantly. water in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. the plastic pour bottle is fabricated from specially formulated polyolefin. the polyolefin is a copolymer of ethylene and propylene. the container requires no vapor barrier.

How Supplied:

16 how supplied/storage and handling sterile water for irrigation is supplied in single-dose plastic pour bottles and flexible plastic containers as follows: container product codes fill volume (ml) ndc plastic pour bottle 2f7112 250 0338-0004-02 2f7113 500 0338-0004-03 2f7114 1000 0338-0004-04 2f7115 1500 0338-0004-05 flexible plastic container 2b7114 1000 0338-0003-44 2b7116 2000 0338-0003-46 2b7117 3000 0338-0003-47 storage exposure of pharmaceutical products to heat should be minimized. avoid excessive heat. store at room temperature (25°c): brief exposure up to 40°c does not adversely affect the product.

Information for Patients:

17 patient counseling information inform patients, caregivers, or home healthcare providers of the following risks of sterile water for irrigation: • hypotonicity [see warnings and precautions (5.1) ] • excessive water absorption [see warnings and precautions (5.2) ]

Package Label Principal Display Panel:

Package/label principal display panel container label 2f7114 ndc 0338-0004-04 1000 ml baxter logo not for injection for irrigation only sterile water for irrigation usp prepared by distillation. no antimicrobial agent or other substance has been added. ph 5.5 (5.0 to 7.0). osmolarity 0 mosmol/l (calc.). sterile, nonpyrogenic. pour bottle. warning: this solution is not isotonic and is hemolytic. dosage and administration: as directed by a physician. cautions: warm in oven to not more than 50ºc for a maximum of 60 days. discard after 60 days of warming. do not use unless solution is clear and seal is intact. discard unused portion. rx only. recommended storage: room temperature (25ºc). avoid excessive heat. pl 325 plastic baxter healthcare corporation deerfield, il 60015 usa made in usa lot exp fpo (91)0709000246 bar code 07-09-00-0246 bar code position only* 303380004041 carton label sterile water for irrigation, usp pour bottle 1000 ml qty 12 ndc 0338-0004-04 2f7114 exp jun 08 lot #g012345 bar code (01)50303380004046(17)080630(10)g012345 lot exp 2000 ml not for injection 2b7116 ndc 0338-0003-46 sterile water for irrigation usp for irrigation only prepared by distillation no antimicrobial agent or other substance has been added ph 5.5 (5.0 to 7.0). osmolarity 0 mosmol/l (calc) sterile nonpyrogenic single dose container do not use unless fluid is clear discard unused portion cautions this fluid is not isotonic and is hemolytic squeeze and inspect inner bag which maintains product sterility discard if leaks are found rx only store unit in moisture barrier overwrap at room temperature (25ºc) until ready to use avoid excessive heat see insert sterile water h 2 0 for irrigation usp uromatic container baxter logo baxter healthcare corporation deerfield il 60015 usa made in usa pl 146 plastic baxter uromatic and pl 146 are trademarks of baxter international inc for product information 1-800-933-0303 1800 1600 1400 1200 1000 800 600 400 200 representative bottle label 0338-0004-04 representative container label 0338-0004-04 2f7114 representative container label 0338-0003-46 representative sample


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.